Your browser doesn't support javascript.
loading
What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?
Giannone, Gaia; Milani, Andrea; Geuna, Elena; Galizia, Danilo; Biello, Federica; Montemurro, Filippo.
Affiliation
  • Giannone G; a Medical Oncology , Candiolo Cancer Institute-FPO, IRCCS , Candiolo , Italy.
  • Milani A; b Medical School , University of Turin , Turin , Italy.
  • Geuna E; c Investigational and Clinical Oncology , Candiolo Cancer Institute-FPO, IRCCS , Candiolo , Italy.
  • Galizia D; c Investigational and Clinical Oncology , Candiolo Cancer Institute-FPO, IRCCS , Candiolo , Italy.
  • Biello F; c Investigational and Clinical Oncology , Candiolo Cancer Institute-FPO, IRCCS , Candiolo , Italy.
  • Montemurro F; c Investigational and Clinical Oncology , Candiolo Cancer Institute-FPO, IRCCS , Candiolo , Italy.
Expert Opin Pharmacother ; 20(1): 5-9, 2019 01.
Article in En | MEDLINE | ID: mdl-30396301
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom